Literature DB >> 3385216

Percutaneous absorption of retinoids: influence of vehicle, light exposure, and dose.

P A Lehman1, J T Slattery, T J Franz.   

Abstract

The percutaneous absorption characteristics of isotretinoin, etretinate, tretinoin, and acitretin were investigated in vitro to assess the feasibility of their topical application for dermatological disorders. The influence of vehicle, photodegradation, and dose was examined. Retinoid absorption through monkey skin was highly vehicle dependent and followed the order: propylene glycol = isopropyl alcohol greater than mineral oil greater than diisopropyl adipate greater than polyethylene glycol 400. Peak flux of etretinate (an ester) was less than 50% that of the acid retinoids in both human and monkey skin. Exposure to light caused a 60% degradation of isotretinoin on the surface of the skin, but did not change the amount of drug which penetrated the epidermis. In accord with this result, the amount of isotretinoin and acitretin which penetrated epidermis did not increase in proportion to dose over a 25-fold range of dose in human skin. Dermal concentration at doses of 10 micrograms/cm2 of isotretinoin and acitretin were greater than that reported for shave biopsies of human skin following treatment for several months with clinically effective doses of isotretinoin and etretinate (the parent ester of the acid acitretin).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3385216     DOI: 10.1111/1523-1747.ep12463289

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

1.  Ingredients tracking of cosmetic formulations in the skin: a confocal Raman microscopy investigation.

Authors:  Matthias Förster; Marie-Alexandrine Bolzinger; Delphine Ach; Gilles Montagnac; Stephanie Briançon
Journal:  Pharm Res       Date:  2011-01-07       Impact factor: 4.200

2.  Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent.

Authors:  Navjot Kaur; Richa Puri; Subheet Kumar Jain
Journal:  AAPS PharmSciTech       Date:  2010-03-24       Impact factor: 3.246

3.  In vitro absorption of some chlorinated paraffins through human skin.

Authors:  R C Scott
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

4.  Polymer conjugated retinoids for controlled transdermal delivery.

Authors:  Steven A Castleberry; Mohiuddin A Quadir; Malak Abu Sharkh; Kevin E Shopsowitz; Paula T Hammond
Journal:  J Control Release       Date:  2017-07-06       Impact factor: 9.776

5.  Promising potency of retinoic acid-poly(ethylene glycol)-thiol gold nanoparticle conjugates for cervical cancer treatment.

Authors:  Li Ye; Qian Song
Journal:  Int J Clin Exp Med       Date:  2015-07-15

6.  Investigation of cis-trans isomer dependent dermatotoxicokinetics of UV filter ethylhexyl methoxycinnamate through stratum corneum in vivo.

Authors:  Anežka Sharma; Katarína Bányiová; Branislav Vrana; Ivan Justan; Pavel Čupr
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-17       Impact factor: 4.223

7.  Topical treatment of ichthyoses and Darier's disease with 13-cis-retinoic acid. A clinical and immunohistochemical study.

Authors:  P M Steijlen; D O Reifenschweiler; F C Ramaekers; G N van Muijen; R Happle; M Link; D J Ruiter; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

8.  In vivo skin penetration of acitretin in volunteers using three sampling techniques.

Authors:  C Surber; K P Wilhelm; D Bermann; H I Maibach
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

9.  Nanoparticle coated submicron emulsions: sustained in-vitro release and improved dermal delivery of all-trans-retinol.

Authors:  Nasrin Ghouchi Eskandar; Spomenka Simovic; Clive A Prestidge
Journal:  Pharm Res       Date:  2009-04-22       Impact factor: 4.200

10.  Retinoic acid morpholine amide (RAMA) inhibits expression of Fas ligand through EP1 receptor in colon cancer cells.

Authors:  Shao-Xuan Chen; Shi-Yu Du; Yun-Ting Wang; Hong-Chuan Zhao; Yan-Li Zhang; Li Yao
Journal:  Tumour Biol       Date:  2015-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.